Orthofix has appointed Max Reinhardt as the new president of its global spine business. Reinhardt, who previously held a leadership position at Pacira Biosciences, will oversee SeaSpine, the company’s global spine and biologics business. With experience at companies like Johnson & Johnson and DePuy Synthes, Reinhardt brings strong leadership and a track record of success to Orthofix. CEO Massimo Calafiore expressed excitement about Reinhardt’s appointment, noting his expertise in driving innovation and commercial success. Reinhardt aims to continue introducing new products and solutions to the market and providing exceptional support for surgeons and patients.
Source link